Therapy Areas: Vaccines
Scancell partners with NHS Cancer Vaccine Launch Pad to accelerate melanoma trial recruitment
14 April 2025 -

Immunotherapy company Scancell Holdings plc (LSE:SCLP) announced on Monday that it has entered into a strategic partnership with the...

Orexo reports positive results for powder-based intranasal vaccine using AmorphOX technology
10 April 2025 - Swedish pharmaceutical company Orexo AB (STO:ORX) (OTCQX:ORXOY) on Thursday reported positive in-vivo proof-of-concept data for a powder-based intranasal influenza vaccine formulated w...
GC Biopharma's BARYTHRAX receives Korean regulatory approval
10 April 2025 - South Korean biopharmaceutical company GC Biopharma announced on Wednesday that it has received approval from the Korean Ministry of Food and Drug Safety (MFDS) for its anthrax vaccine...
GSK grants USD2m to boost adult vaccination efforts
9 April 2025 - Biopharmaceutical company GSK plc (LSE/: GSK ) (NYSE: GSK) announced on Wednesday that it has awarded USD2m in grant funding to 15 public health organisations through its COiMMUNITY Ini...
Valneva and LimmaTech begin Phase 2 infant trial for Shigella vaccine candidate S4V2
9 April 2025 - Vaccine company Valneva SE (Nasdaq:VALN) (Euronext Paris:VLA) and LimmaTech Biologics AG, a clinical-stage biotech company, announced on Wednesday the start of a Phase 2 clinical trial ...
Circio Holding and Entos Pharmaceuticals collaborate on circular RNA delivery
3 April 2025 - Biotechnology company Circio Holding ASA (OSE:CRNA) and Entos Pharmaceuticals U.K. Ltd, a clinical-stage genetic medicines company, on Thursday announced a research collaboration to adv...